ENDEFR
Home › Japan › あゆみ製薬ホールディングス株式会社

あゆみ製薬ホールディングス株式会社

株式会社 (株) · 東京都 中央区, Japan · LEI 353800TKS58G66J4AC31
LEI active

Summary

あゆみ製薬ホールディングス株式会社 is registered in Japan and entered in the “Companies Registration” under number 0100-03-029474. Its legal form is 株式会社 (株) – joint-stock company (Japan). According to GLEIF, its ultimate parent is 株式会社ジーエヌアイグループ (Japan), which is also its direct parent. That group has 2 subsidiaries with LEIs in 1 country, 2 of them in Japan. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 24 Nov 2022 and the record was last updated on 24 Nov 2025; the next renewal is due by 24 Nov 2026.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal form株式会社 (株)
joint-stock company (Japan)
RegisterCompanies Registration · Register website
Registration number0100-03-029474
Registration authorityLegal Affairs Bureau
JurisdictionJapan
Registered address銀座四丁目12番15号, 104-0061 東京都 中央区, Japan
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)7 Mar 2019
LEI353800TKS58G66J4AC31
LEI statusactive
LEI first issued24 Nov 2022
LEI record last updated24 Nov 2025
Next LEI renewal24 Nov 2026
Corroboration of the LEI recordfully corroborated

Group membership

株式会社ジーエヌアイグループ Japan ultimate parent
あゆみ製薬ホールディングス株式会社 this entity
あゆみ製薬株式会社 Japan
View the whole group: 2 subsidiaries in 1 countries

Relationship to the parent

Direct parentUltimate parent
Parent株式会社ジーエヌアイグループ株式会社ジーエヌアイグループ
Accounting period1 Jan 2025 to 31 Dec 20251 Jan 2025 to 31 Dec 2025
Evidencesupporting documentssupporting documents
Corroborationfully corroboratedfully corroborated
Accounting standardIFRSIFRS
Relationship start1 Jul 20261 Jul 2026
Recorded at GLEIF since21 Jul 202621 Jul 2026
Last updated21 Jul 202621 Jul 2026
Record statuscurrentcurrent

Direct subsidiaries (1)

Other names

  • AYUMI Pharmaceutical Holdings KK · name in another language